JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Askonas, L. J.
Right arrow Articles by Smith, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Askonas, L. J.
Right arrow Articles by Smith, W. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Vol. 300, Issue 2, 577-582, February 2002

Pharmacological Characterization of SC-57461A (3-[Methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic Acid HCl), a Potent and Selective Inhibitor of Leukotriene A4 Hydrolase I: In Vitro Studies

Leslie J. Askonas, James F. Kachur, Doreen Villani-Price, Chi-Dean D. Liang, Mark A. Russell and Walter G. Smith

Pharmacia Research and Development, Skokie, Illinois

Leukotriene (LT) B4 is an inflammatory mediator that has been implicated in the pathogenesis of various diseases, including inflammatory bowel disease and psoriasis. As the rate-limiting step for LTB4 production, LTA4 hydrolase represents an attractive target for therapeutic agents that interfere with LTB4 production. In the present study we evaluated a chemically novel compound designated SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl) as an inhibitor of LTA4 hydrolase. Pharmacological comparisons are made to its free acid SC-57461. SC-57461A is a potent competitive inhibitor of recombinant human LTA4 hydrolase when either LTA4 (IC50 = 2.5 nM, Ki = 23 nM) or peptide substrates (IC50 = 27 nM) are used. In human whole blood, the IC50 for calcium ionophore-induced LTB4 production was 49 nM, indicative of good cell penetration. Whole blood production of the cyclooxygenase metabolite thromboxane B2 was not affected. SC-57461A was also active in several other species, including mouse, rat, dog, and rhesus monkey. The data indicate that SC-57461A is a potent and selective inhibitor of LTA4 hydrolase.

0022-3565/02/3002-0577$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J Biomol ScreenHome page
A. M. Liang, E. Claret, J. Ouled-Diaf, A. Jean, D. Vogel, D. R. Light, S. W. Jones, W. J. Guilford, J. F. Parkinson, and R. M. Snider
Development of a Homogeneous Time-Resolved Fluorescence Leukotriene B4 Assay for Determining the Activity of Leukotriene A4 Hydrolase
J Biomol Screen, June 1, 2007; 12(4): 536 - 545.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
J. Z. Haeggstrom
Leukotriene A4 Hydrolase/Aminopeptidase, the Gatekeeper of Chemotactic Leukotriene B4 Biosynthesis
J. Biol. Chem., December 3, 2004; 279(49): 50639 - 50642.
[Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. J. Askonas, J. F. Kachur, D. Villani-Price, C.-D. D. Liang, M. A. Russell, and W. G. Smith
Pharmacological Characterization of SC-57461A (3-[Methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic Acid HCl), a Potent and Selective Inhibitor of Leukotriene A4 Hydrolase I: In Vitro Studies
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 577 - 582.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. F. Kachur, L. J. Askonas, D. Villani-Price, N. Ghoreishi-Haack, S. Won-Kim, C.-D. D. Liang, M. A. Russell, and W. G. Smith
Pharmacological Characterization of SC-57461A (3-[Methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic Acid HCl), a Potent and Selective Inhibitor of Leukotriene A4 Hydrolase II: In Vivo Studies
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 583 - 587.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.